141 related articles for article (PubMed ID: 16423269)
1. Alveolar macrophages and emphysema in surfactant protein-D-deficient mice.
Yoshida M; Whitsett JA
Respirology; 2006 Jan; 11 Suppl():S37-40. PubMed ID: 16423269
[TBL] [Abstract][Full Text] [Related]
2. Design-based stereological analysis of the lung parenchymal architecture and alveolar type II cells in surfactant protein A and D double deficient mice.
Jung A; Allen L; Nyengaard JR; Gundersen HJ; Richter J; Hawgood S; Ochs M
Anat Rec A Discov Mol Cell Evol Biol; 2005 Oct; 286(2):885-90. PubMed ID: 16086431
[TBL] [Abstract][Full Text] [Related]
3. Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema.
Hirama N; Shibata Y; Otake K; Machiya J; Wada T; Inoue S; Abe S; Takabatake N; Sata M; Kubota I
Respirology; 2007 Mar; 12(2):191-201. PubMed ID: 17298450
[TBL] [Abstract][Full Text] [Related]
4. Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways.
Yoshida M; Korfhagen TR; Whitsett JA
J Immunol; 2001 Jun; 166(12):7514-9. PubMed ID: 11390505
[TBL] [Abstract][Full Text] [Related]
5. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice.
Wert SE; Yoshida M; LeVine AM; Ikegami M; Jones T; Ross GF; Fisher JH; Korfhagen TR; Whitsett JA
Proc Natl Acad Sci U S A; 2000 May; 97(11):5972-7. PubMed ID: 10801980
[TBL] [Abstract][Full Text] [Related]
6. A recombinant fragment of human surfactant protein D lacking the short collagen-like stalk fails to correct morphological alterations in lungs of SP-D deficient mice.
Knudsen L; Wucherpfennig K; Mackay RM; Townsend P; Mühlfeld C; Richter J; Hawgood S; Reid K; Clark H; Ochs M
Anat Rec (Hoboken); 2009 Feb; 292(2):183-9. PubMed ID: 19177340
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection.
LeVine AM; Bruno MD; Huelsman KM; Ross GF; Whitsett JA; Korfhagen TR
J Immunol; 1997 May; 158(9):4336-40. PubMed ID: 9126996
[TBL] [Abstract][Full Text] [Related]
8. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.
Atochina EN; Gow AJ; Beck JM; Haczku A; Inch A; Kadire H; Tomer Y; Davis C; Preston AM; Poulain F; Hawgood S; Beers MF
J Infect Dis; 2004 Apr; 189(8):1528-39. PubMed ID: 15073692
[TBL] [Abstract][Full Text] [Related]
9. Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice.
Knudsen L; Ochs M; Mackay R; Townsend P; Deb R; Mühlfeld C; Richter J; Gilbert F; Hawgood S; Reid K; Clark H
Respir Res; 2007 Oct; 8(1):70. PubMed ID: 17915009
[TBL] [Abstract][Full Text] [Related]
10. GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice.
Ochs M; Knudsen L; Allen L; Stumbaugh A; Levitt S; Nyengaard JR; Hawgood S
Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1333-41. PubMed ID: 15310555
[TBL] [Abstract][Full Text] [Related]
11. Surfactant catabolism.
Ikegami M
Respirology; 2006 Jan; 11 Suppl():S24-7. PubMed ID: 16423266
[TBL] [Abstract][Full Text] [Related]
12. Natural IgM and innate immune collectin SP-D bind to late apoptotic cells and enhance their clearance by alveolar macrophages in vivo.
Litvack ML; Djiadeu P; Renganathan SD; Sy S; Post M; Palaniyar N
Mol Immunol; 2010; 48(1-3):37-47. PubMed ID: 21035192
[TBL] [Abstract][Full Text] [Related]
13. Role of pulmonary surfactant protein D in innate defense against Candida albicans.
van Rozendaal BA; van Spriel AB; van De Winkel JG; Haagsman HP
J Infect Dis; 2000 Sep; 182(3):917-22. PubMed ID: 10950789
[TBL] [Abstract][Full Text] [Related]
14. NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis.
Knudsen L; Atochina-Vasserman EN; Guo CJ; Scott PA; Haenni B; Beers MF; Ochs M; Gow AJ
PLoS One; 2014; 9(1):e85722. PubMed ID: 24465666
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein-D regulates soluble CD14 through matrix metalloproteinase-12.
Senft AP; Korfhagen TR; Whitsett JA; Shapiro SD; LeVine AM
J Immunol; 2005 Apr; 174(8):4953-9. PubMed ID: 15814723
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus.
LeVine AM; Elliott J; Whitsett JA; Srikiatkhachorn A; Crouch E; DeSilva N; Korfhagen T
Am J Respir Cell Mol Biol; 2004 Aug; 31(2):193-9. PubMed ID: 15016617
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary surfactant proteins and lipids as modulators of inflammation and innate immunity.
Chiba H; Piboonpocanun S; Mitsuzawa H; Kuronuma K; Murphy RC; Voelker DR
Respirology; 2006 Jan; 11 Suppl():S2-6. PubMed ID: 16423264
[TBL] [Abstract][Full Text] [Related]
18. Lung remodeling in aging surfactant protein D deficient mice.
Schneider JP; Arkenau M; Knudsen L; Wedekind D; Ochs M
Ann Anat; 2017 May; 211():158-175. PubMed ID: 28185902
[TBL] [Abstract][Full Text] [Related]
19. Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema.
Hawgood S; Ochs M; Jung A; Akiyama J; Allen L; Brown C; Edmondson J; Levitt S; Carlson E; Gillespie AM; Villar A; Epstein CJ; Poulain FR
Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1002-10. PubMed ID: 12376353
[TBL] [Abstract][Full Text] [Related]
20. Targeted Disruption of Ig-Hepta/Gpr116 Causes Emphysema-like Symptoms That Are Associated with Alveolar Macrophage Activation.
Ariestanti DM; Ando H; Hirose S; Nakamura N
J Biol Chem; 2015 Apr; 290(17):11032-40. PubMed ID: 25778400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
